Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo

Poor penetration of therapeutic drugs into tumors is a major challenge in anticancer therapy, especially in solid tumors, leading to reduced therapeutic efficacy in vivo. In the study, we used a new tumor-penetrating peptide, CRGDK, to conjugate onto the surface of doxorubicin encapsulated nanoscale...

Full description

Saved in:
Bibliographic Details
Published inNano letters Vol. 13; no. 6; pp. 2528 - 2534
Main Authors Wei, Tuo, Liu, Juan, Ma, Huili, Cheng, Qiang, Huang, Yuanyu, Zhao, Jing, Huo, Shuaidong, Xue, Xiangdong, Liang, Zicai, Liang, Xing-Jie
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 12.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Poor penetration of therapeutic drugs into tumors is a major challenge in anticancer therapy, especially in solid tumors, leading to reduced therapeutic efficacy in vivo. In the study, we used a new tumor-penetrating peptide, CRGDK, to conjugate onto the surface of doxorubicin encapsulated nanoscale micelles. The CRGDK peptide triggered specific binding to neuropilin-1, leading to enhanced cellular uptake and cytotoxicity in vitro and highly accumulation and penetration in the tumors in vivo.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1530-6984
1530-6992
1530-6992
DOI:10.1021/nl400586t